Previous 10 | Next 10 |
HAMPTON, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented promising data from the Company’s growing bispecific and TAM (Tyro3, Axl, MerTK) receptor programs during poster sessions today at the American Association for Cancer Research (AACR) ...
Celldex Therapeutics, Inc. (CLDX) Q4 2018 Results Earnings Conference Call March 07, 2019, 04:30 PM ET Company Participants Sarah Cavanaugh - Senior Vice President, Corporate Affairs and Administration Anthony Marucci - Co-Founder, President, Chief Executive Officer Tibor Keler -...
Celldex (NASDAQ: CLDX ): Q4 GAAP EPS of -$0.81 beats by $0.39 . Revenue of $1.76M (-49.1% Y/Y) beats by $0.3M . Press Release More news on: Celldex Therapeutics, Inc, Earnings news and commentary, Healthcare stocks news, ,
HAMPTON, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31, 2018. The Company will host a conference call at 4:30 p.m. ET today to provide an update on its pipe...
HAMPTON, N.J., March 01, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release fourth quarter and year-end 2018 financial results on Thursday, March 7, 2019 after the U.S. financial markets close. Celldex executives will host a conference call at 4:30 p.m. ET on the...
Gainers: SPI Energy (NASDAQ: SPI ) +45% . SilverSun Technologies (NASDAQ: SSNT ) +30% . Proteostasis Therapeutics (NASDAQ: PTI ) +26% . Enochian Biosciences ( OTCQB:ENOB ) +20% . Nemaura Medical (NASDAQ: NMRD ) +19% . Select Interior Concepts (NASDAQ: SIC ) +18% . Replimune Gro...
HENDERSON, NV / ACCESSWIRE / February 11, 2019 / Investing in biotech companies can provide investors with huge gains. With that in mind, we're highlighting a few you should know about. One you should research right away, BioRestorative Therapies, Inc. (BRTX) a life sciences company foc...
Celldex Therapeutics (NASDAQ: CLDX ) -11% . More news on: Celldex Therapeutics, Inc, Eyenovia, Inc., Avaya Holdings Corp., Stocks on the move, Read more ...
HAMPTON, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) (“Celldex” or the “Company”) today announced that its Board of Directors has approved a one-for-fifteen reverse stock split of its common stock that became effective today u...
CORAL GABLES, FL / ACCESSWIRE / February 5, 2019 / The healthcare stock market has been a hotbed of excitement over the course of the past couple of years as companies across the healthcare industry have employed more nuanced approaches to how they offer care to patients. Unlike other indu...
News, Short Squeeze, Breakout and More Instantly...
Celldex Therapeutics Inc. Company Name:
CLDX Stock Symbol:
NASDAQ Market:
Celldex Therapeutics Inc. Website:
- EMBARQ-CSU1 and EMBARQ-CSU 2 will enroll more than 1800 patients suffering from CSU - - Studies include both biologic naïve and experienced patients - HAMPTON, N.J., July 16, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today the initiation of its...
2024-06-17 18:00:08 ET Alex Thompson from Stifel Nicolaus issued a price target of $58.00 for CLDX on 2024-06-17 16:15:00. The adjusted price target was set to $58.00. At the time of the announcement, CLDX was trading at $34.91. The overall price target consensus is at $...
2024-06-10 19:15:02 ET Wolfe Research analyst issues OUTPERFORM recommendation for CLDX on June 10, 2024 06:14PM ET. CLDX was trading at $34.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy, 1 -...